Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
Objectives The TP53 mutation, a prevalent tumor suppressor gene alteration, is linked to chemotherapy resistance, increased relapse rates and diminished overall survival (OS) in acute myeloid leukemia (AML) patients.Methods In this study, we characterize the TP53 mutation phenotypes across various A...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2024-12-01
|
| Sarja: | Hematology |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2400620 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|